The salivary biomarkers market is projected to grow from USD 569.4 million in 2026 to USD 1,411.1 million by 2036, at a CAGR of 9.5%. Diagnostic assay kits will dominate with a 50.0% market share, while disease diagnostics will lead the application segment with a 60.0% share.